How Jeffrey Epstein used Harvard scientists to rebuild his image and chase influence

Documents also reveal how Epstein viewed science as a tool for image repair.

• Epstein secretly funded Harvard-linked science after 2008 ban
• He invested in Harvard-linked genetics projects through a company.
• Harvard faculty kept ties with Epstein despite official cutoff

Did our AI summary help?

In 2008, Jeffrey Epstein became too radioactive even for institutions used to controversial donors. After his conviction for soliciting prostitution, including from a minor, Harvard University quietly decided it would no longer accept his money.

Publicly, the relationship was meant to be over.Privately, it wasn’t.

Emails released by the Justice Department and newly examined public records show that Epstein continued to channel money, access and influence toward Harvard scientists for years after the official cutoff.

His focus narrowed on biology and genetics, fields he believed could give him intellectual prestige and proximity to powerful academic networks. The strategy was simple: if he could no longer donate openly, he would fund people, projects and even companies linked to Harvard instead, CNN reported.

A private investment vehicle with academic cover

Central to that effort was a little-known company called Georgarage. On paper, it looked like an investment vehicle connected to a famous Harvard geneticist. In practice, the money and control traced back to Epstein.

The emails show Epstein working closely with George Church, a prominent geneticist known for ambitious projects including gene editing and de-extinction research. Church laid out detailed proposals for investments in gene-editing startups, longevity research and virus-resistant animals. Epstein responded with encouragement and instructions, including telling Church to choose a name for the investment company.

Though the branding suggested Church’s leadership, incorporation records show the company was set up by Epstein’s longtime lawyer, with Epstein overseeing decisions. Startup executives treated Epstein as the real decision-maker, sending him investment terms and seeking his approval. There is no evidence the company ultimately made major investments, but the structure itself mattered. It placed Epstein inside cutting-edge science, without his name appearing on university donation rolls.

Deeper ties than Harvard admitted

Epstein’s relationship with Church was not isolated. He also had extensive ties with Martin Nowak, a Harvard biologist who ran the Program for Evolutionary Dynamics. Epstein funded the program’s offices, used them as a base in Cambridge and retained key-card access to Harvard buildings as late as 2018, according to Harvard’s own investigation.

Previously unreleased photographs appear to show Church and Nowak visiting Epstein’s private island. Harvard later sanctioned Nowak for his role in maintaining the relationship, but neither professor was dismissed. Both remain affiliated with the university.

Crucially, none of the scientists involved have been accused of participating in Epstein’s crimes. The issue is not criminal conduct, but judgment, access and the quiet normalization of a donor whose reputation had already collapsed.

Science as reputation management

The documents also reveal how Epstein viewed science as a tool for image repair. Emails discuss placing press stories about research he funded, with the explicit goal of pushing negative coverage down search results. When that effort failed to drown out reporting on his crimes, Epstein complained that the articles were too infrequent. He wanted constant visibility, not silence.

This pattern fits what investigators have found elsewhere. Epstein did not just seek intellectual stimulation. He sought proximity to legitimacy. Elite scientists offered him a way back into respectable rooms, long after universities claimed they had closed the door.

An institutional failure, not a single lapse

Harvard’s 2020 internal review concluded that administrators knew Epstein was still indirectly involved in donations years after the ban. Faculty members continued to meet him on campus. Invitations continued. Oversight failed.

The newly released records deepen that picture. They show a financier who understood academic culture well enough to exploit its blind spots, and a system that relied too heavily on informal boundaries and personal assurances. Epstein’s money did not buy absolution. But it bought time, access and influence long after it should have been refused.